113 related articles for article (PubMed ID: 36920369)
1. Differences in Merkel Cell Carcinoma Presentation and Outcomes Among Racial and Ethnic Groups.
Mohsin N; Martin MR; Reed DJ; Vilasi SM; Miao L; Hill NT; Brownell I
JAMA Dermatol; 2023 May; 159(5):536-540. PubMed ID: 36920369
[TBL] [Abstract][Full Text] [Related]
2. Differential Outcomes Among Survivors of Head and Neck Cancer Belonging to Racial and Ethnic Minority Groups.
Taylor DB; Osazuwa-Peters OL; Okafor SI; Boakye EA; Kuziez D; Perera C; Simpson MC; Barnes JM; Bulbul MG; Cannon TY; Watts TL; Megwalu UC; Varvares MA; Osazuwa-Peters N
JAMA Otolaryngol Head Neck Surg; 2022 Feb; 148(2):119-127. PubMed ID: 34940784
[TBL] [Abstract][Full Text] [Related]
3. Head and Neck Cancer Stage at Presentation and Survival Outcomes Among Native Hawaiian and Other Pacific Islander Patients Compared With Asian and White Patients.
Moon PK; Ma Y; Megwalu UC
JAMA Otolaryngol Head Neck Surg; 2022 Jul; 148(7):636-645. PubMed ID: 35616952
[TBL] [Abstract][Full Text] [Related]
4. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
Sung H; Wiese D; Jatoi I; Jemal A
JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
[TBL] [Abstract][Full Text] [Related]
5. Racial and Ethnic Disparities in Survival Among People With Second Primary Cancer in the US.
Sung H; Nisotel L; Sedeta E; Islami F; Jemal A
JAMA Netw Open; 2023 Aug; 6(8):e2327429. PubMed ID: 37540510
[TBL] [Abstract][Full Text] [Related]
6. Racial and Ethnic Disparities in Use of Novel Hormonal Therapy Agents in Patients With Prostate Cancer.
Ma TM; Agarwal N; Mahal B; Barragan-Carrillo R; Spratt D; Rettig MB; Valle LF; Steinberg ML; Garraway I; Vapiwala N; Xiang M; Kishan AU
JAMA Netw Open; 2023 Dec; 6(12):e2345906. PubMed ID: 38039002
[TBL] [Abstract][Full Text] [Related]
7. Racial and Ethnic Bias in Risk Prediction Models for Colorectal Cancer Recurrence When Race and Ethnicity Are Omitted as Predictors.
Khor S; Haupt EC; Hahn EE; Lyons LJL; Shankaran V; Bansal A
JAMA Netw Open; 2023 Jun; 6(6):e2318495. PubMed ID: 37318804
[TBL] [Abstract][Full Text] [Related]
8. Response to Treatment, Racial and Ethnic Disparity, and Survival in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy in the US.
Shubeck S; Zhao F; Howard FM; Olopade OI; Huo D
JAMA Netw Open; 2023 Mar; 6(3):e235834. PubMed ID: 36995711
[TBL] [Abstract][Full Text] [Related]
9. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
10. Differences in Stage of Cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading Cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract][Full Text] [Related]
11. Association of Medicaid Expansion With Mortality Disparity by Race and Ethnicity Among Patients With De Novo Stage IV Breast Cancer.
Malinowski C; Lei X; Zhao H; Giordano SH; Chavez-MacGregor M
JAMA Oncol; 2022 Jun; 8(6):863-870. PubMed ID: 35389432
[TBL] [Abstract][Full Text] [Related]
12. Association of Race and Ethnicity With Comorbidities and Survival Among Patients With COVID-19 at an Urban Medical Center in New York.
Kabarriti R; Brodin NP; Maron MI; Guha C; Kalnicki S; Garg MK; Racine AD
JAMA Netw Open; 2020 Sep; 3(9):e2019795. PubMed ID: 32975574
[TBL] [Abstract][Full Text] [Related]
13. Associations Between Race/Ethnicity and US Childhood and Adolescent Cancer Survival by Treatment Amenability.
Delavar A; Barnes JM; Wang X; Johnson KJ
JAMA Pediatr; 2020 May; 174(5):428-436. PubMed ID: 32091555
[TBL] [Abstract][Full Text] [Related]
14. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States.
Iqbal J; Ginsburg O; Rochon PA; Sun P; Narod SA
JAMA; 2015 Jan; 313(2):165-73. PubMed ID: 25585328
[TBL] [Abstract][Full Text] [Related]
15. Effect of host, tumor, diagnostic, and treatment variables on outcomes in a large cohort with Merkel cell carcinoma.
Asgari MM; Sokil MM; Warton EM; Iyer J; Paulson KG; Nghiem P
JAMA Dermatol; 2014 Jul; 150(7):716-23. PubMed ID: 24807619
[TBL] [Abstract][Full Text] [Related]
16. Mediation of Racial and Ethnic Inequities in the Diagnosis of Advanced-Stage Cervical Cancer by Insurance Status.
Holt HK; Peterson CE; MacLaughlan David S; Abdelaziz A; Sawaya GF; Guadamuz JS; Calip GS
JAMA Netw Open; 2023 Mar; 6(3):e232985. PubMed ID: 36897588
[TBL] [Abstract][Full Text] [Related]
17. Racial and Ethnic Disparities in Clinical Trial Enrollment Among Women With Gynecologic Cancer.
Khadraoui W; Meade CE; Backes FJ; Felix AS
JAMA Netw Open; 2023 Dec; 6(12):e2346494. PubMed ID: 38060227
[TBL] [Abstract][Full Text] [Related]
18. Survival Outcomes by Race and Ethnicity in Veterans With Nonmetastatic Castration-Resistant Prostate Cancer.
Rasmussen KM; Patil V; Li C; Yong C; Appukkuttan S; Grossman JP; Jhaveri J; Halwani AS
JAMA Netw Open; 2023 Oct; 6(10):e2337272. PubMed ID: 37819658
[TBL] [Abstract][Full Text] [Related]
19. Trends in incidence, treatment and survival of Merkel cell carcinoma in England 2004-2018: a cohort study.
Mistry K; Levell NJ; Hollestein L; Wakkee M; Nijsten T; Knott CS; Steven NM; Craig PJ; Venables ZC
Br J Dermatol; 2023 Feb; 188(2):228-236. PubMed ID: 36763882
[TBL] [Abstract][Full Text] [Related]
20. Racial and Ethnic Discrepancy in Pulse Oximetry and Delayed Identification of Treatment Eligibility Among Patients With COVID-19.
Fawzy A; Wu TD; Wang K; Robinson ML; Farha J; Bradke A; Golden SH; Xu Y; Garibaldi BT
JAMA Intern Med; 2022 Jul; 182(7):730-738. PubMed ID: 35639368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
